D.K. Biswas
Division of Cancer Biology
Dana-Farber Cancer Institute
Boston
Massachusetts
USA
Name/email consistency: high
- A therapeutic target for hormone-independent estrogen receptor-positive breast cancers. Biswas, D.K., Cruz, A., Pettit, N., Mutter, G.L., Pardee, A.B. Mol. Med. (2001)
- The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Biswas, D.K., Dai, S.C., Cruz, A., Weiser, B., Graner, E., Pardee, A.B. Proc. Natl. Acad. Sci. U.S.A. (2001)
- Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Biswas, D.K., Cruz, A.P., Gansberger, E., Pardee, A.B. Proc. Natl. Acad. Sci. U.S.A. (2000)
- Detection of the level of estrogen receptor and functional variants in human breast cancers by novel assays. Biswas, D.K., Cruz, A.P., Pardee, A.B. BioTechniques (2000)
- Classification of breast cancer cells on the basis of a functional assay for estrogen receptor. Biswas, D.K., Averboukh, L., Sheng, S., Martin, K., Ewaniuk, D.S., Jawde, T.F., Wang, F., Pardee, A.B. Mol. Med. (1998)
- Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT. Biswas, D.K., Mhashilkar, A.M., Ewaniuk, D.S., Pezza, J.A., Oh, L.M., Kannangara, G.S., Tius, M.A., Pardee, A.B. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. (1998)
- Calmodulin is essential for estrogen receptor interaction with its motif and activation of responsive promoter. Biswas, D.K., Reddy, P.V., Pickard, M., Makkad, B., Pettit, N., Pardee, A.B. J. Biol. Chem. (1998)